Kiora Pharmaceuticals (KPRX) closed at $1.56 on October 30, 2026, down 11.4% from the previous close, on volume of 99,475 shares (30-day average 30,675).
Data as of October 30, 2026.
No press releases found.
Analysts Are Bullish on Top Healthcare Stocks: PTC Therapeutics (PTCT), Stryker (SYK)
TipRanks (Fri, 30-Oct 2:50 PM ET)
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
Kiora Pharmaceuticals trades on the NASDAQ stock market under the symbol KPRX.
As of October 30, 2026, KPRX stock price declined to $1.56 with 99,475 million shares trading.
KPRX has a beta of 1.35, meaning it tends to be more sensitive to market movements. KPRX has a correlation of 0.07 to the broad based SPY ETF.
KPRX has a market cap of $6.90 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, KPRX traded as high as $8.98 and as low as $1.55.
The top ETF exchange traded funds that KPRX belongs to (by Net Assets): VXF, DXUV, DFAC, DCOR, DFSU.
KPRX has underperformed the market in the last year with a price return of -38.8% while the SPY ETF gained +12.3%. KPRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.9% and -35.0%, respectively, while the SPY returned +2.1% and -1.0%, respectively.
KPRX support price is $1.68 and resistance is $1.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KPRX shares will trade within this expected range on the day.
